Biosimilars for psoriasis: clinical studies to determine similarity
Biosimilars are drugs that are similar, but not identical, to originator biologics. Pre-clinical analytical studies are required to show similarity on a molecular and structural level, but efficacy and safety studies in humans are essential to ultimately determine biosimilarity. In this review writt...
Uloženo v:
Hlavní autoři: | , , , , , , , , , , , , |
---|---|
Médium: | Revisão |
Jazyk: | angličtina |
Vydáno: |
2016
|
On-line přístup: | https://doi.org/10.1111/bjd.15067 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|